文献速递血液净化与透析

血液透析剂量与死亡率:越高越好吗?

Dialysis dose and mortality in haemodialysis: is higher better?
PubMed 文献 · Nephrol Dial Transplant · 2021-01-01

该研究基于全国注册登记中32 283例每周三次血液透析的 incident 患者,分析透析剂量(Kt/V、Kt、Kt/A)与生存的关系。结果显示无论采用何种指标,较高透析剂量均与更好的生存相关,Kt最为显著,上四分位与下四分位5年生存差异达23.6%。

要点

  • 较高透析剂量与更好的生存独立相关,校正混杂因素后关系持续存在。
  • Kt上四分位(>69 L/次)患者生存最佳,与下四分位5年生存差异达23.6%。
  • 动静脉内瘘、血液透析滤过、计划起始透析等因素可预测高Kt。

核心结论

  • 透析剂量与生存之间存在独立于已知混杂因素的关系,较高剂量与更好生存相关。

研究设计与样本

  • 全国注册登记研究,纳入32 283例每周三次血液透析的 incident 患者,具有透析剂量数据。

主要发现

  • 无论采用Kt/V、Kt或Kt/A,较高透析剂量均与更好的生存相关。
  • Kt的生存区分度略优于Kt/V和Kt/A。
  • Kt上四分位(>69 L/次)生存最高,随Kt降低而恶化,上四分位与下四分位5年生存差异23.6%。
  • 将肾移植作为竞争风险校正后,Kt分布间的生存差异相似。
  • 预测Kt处于上四分位的因素包括动静脉内瘘对比导管和移植物、血液透析滤过对比血液透析、计划起始透析对比紧急起始、较长每周透析时间、spKt/V测量对比双池平衡Kt/V。

关键数值与推荐

  • 当前指南推荐每周三次透析时spKt/V目标为1.20-1.40。
  • Kt上四分位定义为>69 L/次。

临床怎么用

  • 临床可参考Kt等指标评估透析剂量,较高剂量与更好生存相关,但需结合患者个体情况。
  • 优先采用动静脉内瘘、血液透析滤过、计划起始透析等可预测高Kt的因素可能有助于提高透析剂量。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The effect of dialysis dose on mortality remains unsettled. Current guidelines recommend targeting a single-pool Kt/V (spKt/V) at 1.20-1.40 per thrice-weekly dialysis session. However, the optimal dialysis dose remains mostly disputed. METHODS: In a nationwide registry of all incident patients receiving thrice-weekly haemodialysis, 32 283 patients had available data on dialysis dose, estimated by Kt/V and its variants epuration volume per session (Kt) and Kt indexed to body surface area (Kt/A). Survival was analysed with a multivariate Cox model and a concurrent risk model accounting for renal transplantation. A predictive model of Kt in the upper quartile was developed. RESULTS: Regardless of the indicator, a higher dose of dialysis was consistently associated with better survival. The survival differential of Kt was the most discriminating, but marginally, compared with the survival differential according to Kt/V and Kt/A. Patient survival was higher in the upper quartile of Kt (>69 L/session) then deteriorated as the Kt decreased, with a difference in survival between the upper and lower quartile of 23.6% at 5 years. Survival differences across Kt distribution were similar after accounting for kidney transplantation as a competing risk. Predictive factors for Kt in the upper quartile were arteriovenous fistula versus catheters and graft, haemodiafiltration versus haemodialysis, scheduled dialysis start versus emergency start, long weekly dialysis duration and spKt/V measurement versus double-pool equilibrated Kt/V. CONCLUSIONS: Our data confirm the existence of a relationship between dialysis dose and survival that persisted despite correcting for known confounders. A model for predicting a high dose of dialysis is proposed with practical relevance.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Béguin L, Krummel T, Longlune N, et al. Dialysis dose and mortality in haemodialysis: is higher better? Nephrol Dial Transplant. 2021. PMID: 34145896. doi:10.1093/ndt/gfab202

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。